HIGHLIGHTS
- who: Fabienne Fru00f6hlich from the University of, Gloriastrasse, CHu20118091, Switzerland have published the paper: HLA-B27 as a predictor of effectiveness of treatment with TNF inhibitors in axial spondyloarthritis: data from the Swiss Clinical Quality Management Registry, in the Journal: (JOURNAL)
- what: The aim of this study is to explore the influence of HLA-B27 on the effectiveness of treatment after start of a first TNFi in individuals with axSpA.
SUMMARY
Data on phenotypic differences between HLAB27 positive (B27+) and HLA-B27 negative (B27-) individuals with axial spondyloarthritis (axSpA) continue to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.